Enveric Biosciences Inc (ENVB)

Jun 10, 2026

ENVB SEC FilingsEnveric Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 10, 2026

Jun 09, 2026

Enveric Biosciences Expands At-The-Market Equity Offering - TipRanks

Jun 09, 2026

Jun 09, 2026

Enveric Biosciences (NASDAQ: ENVB) expands $2.4M at-the-market stock program - Stock Titan

Jun 09, 2026

Jun 09, 2026

Enveric Biosciences (ENVB) amends ATM; $2.425M remaining capacity - Stock Titan

Jun 09, 2026

Jun 09, 2026

Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Investing News Network

Jun 09, 2026

Jun 09, 2026

Enveric's High-Stakes Pitch: Selling Neuroplasticity Without the Trip - BriefGlance

Jun 09, 2026

Jun 09, 2026

Enveric Biosciences Releases Updated Investor Presentation Materials - TipRanks

Jun 09, 2026

Jun 09, 2026

Enveric Biosciences posts investor presentation on website under Regulation FD - TradingView

Jun 09, 2026

Jun 08, 2026

Enveric Biosciences (NASDAQ: ENVB) furnishes Q2 2026 investor presentation - Stock Titan

Jun 08, 2026

Jun 08, 2026

Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits

Jun 08, 2026

Jun 05, 2026

ENVB Stock Chart | ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) - ChartMill

Jun 05, 2026

Jun 03, 2026

[Form 4] Enveric Biosciences, Inc. Insider Trading Activity - Stock Titan

Jun 03, 2026

Jun 03, 2026

Enveric Biosciences (ENVB) CFO awarded 133,333 RSUs in long-term equity grant - Stock Titan

Jun 03, 2026

Jun 03, 2026

Enveric Biosciences (ENVB) CEO granted 201,124 RSUs under 2020 long-term plan - Stock Titan

Jun 03, 2026

Jun 03, 2026

Enveric Biosciences (ENVB) director receives 18,518 restricted stock shares as equity grant - Stock Titan

Jun 03, 2026

Jun 03, 2026

Director at Enveric Biosciences (ENVB) receives 18,518 restricted shares - Stock Titan

Jun 03, 2026

Jun 03, 2026

Enveric (ENVB) awards director Marcus Schabacker 18,518 restricted shares - Stock Titan

Jun 03, 2026

Jun 03, 2026

Enveric Biosciences (ENVB) awards 25,000 RSUs to its CIO - Stock Titan

Jun 03, 2026

Jun 02, 2026

Enveric Biosciences (ENVB) Launches Critical Safety Studies for EB-003 - GuruFocus

Jun 02, 2026

Jun 02, 2026

Enveric Biosciences Initiates Investigational New Drug -enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 - Investing News Network

Jun 02, 2026

Jun 02, 2026

Enveric Biosciences stock rises on genotoxicity study launch By Investing.com - Investing.com India

Jun 02, 2026

Jun 02, 2026

Enveric Biosciences stock rises on genotoxicity study launch - Investing.com

Jun 02, 2026

Jun 02, 2026

Enveric Biosciences begins genotoxicity studies for EB-003 - Investing.com

Jun 02, 2026

Jun 02, 2026

Enveric Biosciences begins genotoxicity studies for EB-003 By Investing.com - Investing.com Canada

Jun 02, 2026

Jun 02, 2026

Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 - Business Wire

Jun 02, 2026

May 29, 2026

Enveric Biosciences (NASDAQ: ENVB) holders OK reverse split, block share increase - Stock Titan

May 29, 2026

May 29, 2026

Enveric Biosciences Holds Near Support Amid Modest PullbackPCR Moving Average - thelegaladvocate.com

May 29, 2026

May 29, 2026

ENVB Technical Analysis | Trend, Signals & Chart Patterns | ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) - ChartMill

May 29, 2026

May 29, 2026

Enveric Biosciences Inc Annual Shareholders Meeting Transcript - GuruFocus

May 29, 2026

May 27, 2026

ENVB Stock Price, Quote & Chart | ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) - ChartMill

May 27, 2026

May 25, 2026

Enveric Biosciences Company Profile & Introduction - Moomoo

May 25, 2026

May 24, 2026

Enveric Biosciences Inc. (ENVB) Q4 2024 Earnings: Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue - thelegaladvocate.com

May 24, 2026

May 20, 2026

Enveric Biosciences (ENVB) Achieves Key Milestone in Neuropsychi - GuruFocus

May 20, 2026

May 19, 2026

Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003 - Investing News Network

May 19, 2026

May 17, 2026

Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026 - BioSpace

May 17, 2026

May 17, 2026

Enveric Biosciences 1Q Loss/Shr $1.08 >ENVB - Moomoo

May 17, 2026

May 15, 2026

Enveric Biosciences Inc (ENVB) Stock Price, Quote, News & History - Benzinga

May 15, 2026

May 15, 2026

Enveric Biosciences (ENVB) affiliates report 158,732 warrants; Easton 161,232 - Stock Titan

May 15, 2026

May 15, 2026

Enveric (ENVB) Secures $13.9 Million in Private Placement Fundin - GuruFocus

May 15, 2026

May 15, 2026

Enveric (ENVB) Advances in Mental Health Therapeutics Developmen - GuruFocus

May 15, 2026

May 15, 2026

Enveric Biosciences Reports Q1 2026 Results, Advances Non-Hallucinogenic Antidepressant EB-003 Toward Clinical Trials - Minichart

May 15, 2026

May 15, 2026

Enveric Biosciences Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026

May 15, 2026

Enveric Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

May 15, 2026

Enveric Biosciences (NASDAQ: ENVB) posts Q1 2026 loss and flags going concern risk - Stock Titan

May 15, 2026

May 15, 2026

Enveric Biosciences (ENVB) advances EB-003 and boosts cash in Q1 2026 - Stock Titan

May 15, 2026

May 14, 2026

What's going on with Enveric Biosciences stock on Friday? - MSN

May 14, 2026

May 13, 2026

Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders - Investing News Network

May 13, 2026

May 13, 2026

Enveric highlights preclinical PTSD data amid rising focus on mental health therapies - MSN

May 13, 2026

May 13, 2026

Enveric Biosciences receives patent for psilocybin derivatives By Investing.com - Investing.com Canada

May 13, 2026

May 12, 2026

Enveric Biosciences Stock Short Interest Rises to 45.7% - Moomoo

May 12, 2026